BindingDB logo
myBDB logout

BDBM272144 E1-(abs)-5-(3-fluoro-2-methylphenyl)-N-hydroxy-3- phenyl-5,6-dihydro-4H-cyclopenta[d]isothiazole-5- carboxamide::US10065948, 80::US10457675, Example 80

SMILES: Cc1c(F)cccc1[C@@]1(Cc2snc(c2C1)-c1ccccc1)C(=O)NO

InChI Key: InChIKey=IPSRBEYDLALGLY-HXUWFJFHSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 272144   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone deacetylase 9


(Homo sapiens (Human))
BDBM272144
PNG
(E1-(abs)-5-(3-fluoro-2-methylphenyl)-N-hydroxy-3- ...)
Show SMILES Cc1c(F)cccc1[C@@]1(Cc2snc(c2C1)-c1ccccc1)C(=O)NO |r|
Show InChI InChI=1S/C20H17FN2O2S/c1-12-15(8-5-9-16(12)21)20(19(24)22-25)10-14-17(11-20)26-23-18(14)13-6-3-2-4-7-13/h2-9,25H,10-11H2,1H3,(H,22,24)/t20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 79n/an/an/an/an/an/a



CHDI Foundation, Inc.

US Patent


Assay Description
The potency of the compounds is quantified by measuring the Histone Deacetylase 9 (HDAC9) enzymatic activity using the fluorogenic substrate, Boc-Lys...


US Patent US10457675 (2019)


BindingDB Entry DOI: 10.7270/Q22J6F7J
More data for this
Ligand-Target Pair
Histone deacetylase 9


(Homo sapiens (Human))
BDBM272144
PNG
(E1-(abs)-5-(3-fluoro-2-methylphenyl)-N-hydroxy-3- ...)
Show SMILES Cc1c(F)cccc1[C@@]1(Cc2snc(c2C1)-c1ccccc1)C(=O)NO |r|
Show InChI InChI=1S/C20H17FN2O2S/c1-12-15(8-5-9-16(12)21)20(19(24)22-25)10-14-17(11-20)26-23-18(14)13-6-3-2-4-7-13/h2-9,25H,10-11H2,1H3,(H,22,24)/t20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 79n/an/an/an/an/an/a



CHDI Foundation, Inc.

US Patent


Assay Description
The potency of the compounds is quantified by measuring the Histone Deacetylase 9 (HDAC9) enzymatic activity using the fluorogenic substrate, Boc-Lys...


US Patent US10065948 (2018)


BindingDB Entry DOI: 10.7270/Q2154K23
More data for this
Ligand-Target Pair